University of Minnesota
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Minnesota sits in the top decile of US sponsors by registered trial count (#33 of 15,742 sponsors by registered trial count).
University of Minnesota: 966 sponsored US clinical trials, 180 recruiting.
University of Minnesota sponsors 966 registered US clinical trials on ClinicalTrials.gov, 180 of them currently recruiting, and 671 completed. 71 of these trials are in Phase 3-4 (later-stage) and 206 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 14 trials.
Top-decile sponsor footprint
University of Minnesota ranks in the top decile of sponsors by registered trial count (#33 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
671 of 731 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
966 total, page 1 of 20
Technical Development of Multi-Parametric Renocerebral MRI
NCT02831335
Myofunctional Therapy for Obstructive Sleep Apnea
NCT07301125
Feasibility of a Remotely Delivered Step Count Intervention in Chronic Stroke
NCT07649135
MRI as Noninvasive Innovative Approach in Detection and Monitoring of Malignant Oral Lesions in Fanconi Anemia Patients
NCT07649031
PASCAL Feasibility Study
NCT07301151
The SEAS Study: Sensory Engagement and Activation During Noninvasive Stimulation
NCT07606573
Evaluating Noninvasive Brain Stimulation for TMD Pain: A Feasibility Study
NCT07517172
Fast-Her: Fasting Effects on Breast Cancer Treatment
NCT07624617
Glucose and Activity Tracking for Sedentary Behavior Interventions in Older People With Type 2 Diabetes (TRACK T2D)
NCT07524205
Project REACH: A Comprehensive Telehealth Intervention at Syringe Service Programs to Engage People Who Use Drugs
NCT07433712
A Standardized Counseling Approach to Preoperative Education in Transmasculine Individuals Receiving Gender-affirming Surgery
NCT07324967
Targeting Neuroplasticity for Persistent Post-Concussive Cognitive Symptoms
NCT07246993
Optimizing Accelerated TMS for Chronic Pain With Thompson Sampling
NCT07103135
Assessing Immune Dysfunction in Sepsis
NCT07154615
CE-STAND: Cervical Epidural STimulation After Neurologic Damage
NCT06410001
The Black Immigrant Project
NCT07546708
Percept Transitions in FOG and PD
NCT06848205
Nitric Oxide (NO) and Endothelial Dysfunction in Women With PTSD
NCT07485231
Alternate Nostril Breathing (ANB) for 1st Trimester Nausea and Vomiting
NCT07378839
Effects of Vagal Nerve Stimulation on Leg Muscle Activity and Posture in Parkinson's Disease
NCT07226284
Effects of a 5-Week Probiotic Supplementation Intervention on Markers of Delayed Onset Muscle Soreness
NCT07219498
Combined tDCS and Cognitive Training as an Adjunctive Treatment in Opioid Use Disorder
NCT07158853
mGlide-Care: A Partnership With Caregivers
NCT05850416
Brain Network Changes After Vibro-tactile Stimulation in Laryngeal Dystonia
NCT07443891
HOPE-BP 2.0: Evaluating the Optimal Duration of Postpartum Remote Blood Pressure Monitoring
NCT07204756
Just-in-Time Training for Youth Mentors
NCT07129070
Effect of Vibro-tactile Stimulation Intensity on Head Posture in Cervical Dystonia
NCT07245615
Radiofrequency Ablation/Bone Augmentation + Radiotherapy vs Radiotherapy Alone
NCT07090122
A Window of Opportunity Trial of Mirdametinib Plus Vorinostat for NF1 Associated, H3K27 Trimethylation Deficient Malignant Peripheral Nerve Sheath Tumor [MPNST]
NCT06693284
Cognitive Strategies in Early Psychosis 1
NCT07231497
Dose-Response Effects of Inspiratory Muscle Strength Training on Blood Pressure and Vascular Function
NCT07109739
Elevated Rate Pacing of Cardiac Amyloidosis
NCT07583823
Investigating EEG as a Biomarker for Tinnitus Improvement After Bimodal Stimulation
NCT07158034
CMVIG Prophylaxis in Belatacept Conversion Kidney Transplant Recipients
NCT07096453
A Pilot Study Testing the Safety and Feasibility of Restorative Microbiota Therapy (RMT) in Patients With Refractory Immune-checkpoint Inhibitor-related Colitis
NCT05726396
Baby ABS (Abdominal Binder Study)
NCT07049900
Torque Device Evaluation
NCT07094256
An International Observational Study of Adults With Acute Infection
NCT07069400
Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata
NCT06747611
Choline and Iron Deficiency
NCT06527391
Fastomics: Metabolic and Therapeutic Effects of Prolonged Fasting
NCT07216989
Improving Barriers to Care Access for Children With Autism and Related Needs Via Telehealth for Evaluation, Care Navigating, and Caregiver Coaching
NCT07520838
Personalized Nutrition for Type 2 Diabetes
NCT06784375
DEciphering CIrculating SIgnatures Of Infected Pancreatic Necrosis
NCT06899087
Evaluation of Decision-Making Fatigue After Traumatic Brain Injury
NCT07103200
ADHERE-LPV Advancing Delivery of High-Quality Evidence-Based Respiratory Efforts in Lung-Protective Ventilation
NCT06895148
Cervical and Endometrial Cancer Screening in Patients Seeking Gender-Affirming Hysterectomy
NCT07075731
Medical Cannabis and Behavior
NCT06808048
ConnectedNest: a Digital Platform Connecting Individuals With Cancer to Social Care
NCT06559228
Sustained Release Oral Formulation for Treatment of Parkinson's Disease
NCT05471609
What is open in the University of Minnesota pipeline
180 recruiting of 966 indexed (19% open); 671 completed (69%).
Phase mix: 71 late (III/IV) vs 206 early (I/II) (early-phase heavy).
Top condition: Obesity (14 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Minnesota: open-pipeline peers nationwide
Peers matched on 966 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of Minnesota sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 966 trials (± recruiting share)
- Columbia University · 958 trials · 18% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- Bristol-Myers Squibb · 1,025 trials · 7% recruiting
Sponsors near 19% open enrollment (± trial volume)
- University of Alabama at Birmingham · 19% recruiting · 1,160 trials
- Mclean Hospital · 19% recruiting · 140 trials
- Children's Hospital Medical Center, Cincinnati · 19% recruiting · 571 trials
- Arkansas Children's Hospital Research Institute · 19% recruiting · 97 trials
Related
What to do with this University of Minnesota page
966 registered trials is a research-attention snapshot, not an endorsement of University of Minnesota or any single study.
- 180 of University of Minnesota's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Minnesota studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Minnesota pipeline card: 966 registered trials from official public datasets.Report a data error.